Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | +13.11% | +21.17% | -38.21% |
Apr. 11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
Apr. 11 | Ocuphire Pharma, Inc. Announces Global License Agreement with Viatris Inc | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Official Publications